{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T21:20:39Z","timestamp":1785014439646,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00467-024-06629-6","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T05:02:59Z","timestamp":1736485379000},"page":"1711-1722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of the complement system in Shiga toxin-associated hemolytic uremic syndrome"],"prefix":"10.1007","volume":"40","author":[{"given":"Victoria","family":"Bocanegra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria V.","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea F. Gil","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Miatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Cacciamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eugenia","family":"Benardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Pott","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago Rodr\u00edguez","family":"de C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia G.","family":"Vall\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"6629_CR1","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1681\/ASN.2004100861","volume":"16","author":"M Noris","year":"2005","unstructured":"Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035\u20131050. https:\/\/doi.org\/10.1681\/ASN.2004100861","journal-title":"J Am Soc Nephrol"},{"key":"6629_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.vetmic.2009.04.011","volume":"140","author":"MA Karmali","year":"2010","unstructured":"Karmali MA, Gannon V, Sargeant JM (2010) Verocytotoxin-producing Escherichia coli (VTEC). Vet Microbiol 140:360\u2013370. https:\/\/doi.org\/10.1016\/j.vetmic.2009.04.011","journal-title":"Vet Microbiol"},{"key":"6629_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s004670050248","volume":"11","author":"FD Spizzirri","year":"1997","unstructured":"Spizzirri FD, Rahman RC, Bibiloni N et al (1997) Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 11:156\u2013160. https:\/\/doi.org\/10.1007\/s004670050248","journal-title":"Pediatr Nephrol"},{"key":"6629_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijmm.2016.02.005","volume":"306","author":"L Pianciola","year":"2016","unstructured":"Pianciola L, D\u2019Astek BA, Mazzeo M et al (2016) Genetic features of human and bovine Escherichia coli O157:H7 strains isolated in Argentina. Int J Med Microbiol 306:123\u2013130. https:\/\/doi.org\/10.1016\/j.ijmm.2016.02.005","journal-title":"Int J Med Microbiol"},{"key":"6629_CR5","first-page":"27","volume":"66 Suppl 3","author":"M Rivas","year":"2006","unstructured":"Rivas M, Miliwebsky E, Chinen I et al (2006) The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission. Medicina (B Aires) 66 Suppl 3:27\u201332","journal-title":"Medicina (B Aires)"},{"key":"6629_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00467-017-3850-x","volume":"34","author":"C Zoja","year":"2019","unstructured":"Zoja C, Buelli S, Morigi M (2019) Shiga toxin triggers endothelial and podocyte injury: the role of complement activation. Pediatr Nephrol 34:379\u2013388. https:\/\/doi.org\/10.1007\/s00467-017-3850-x","journal-title":"Pediatr Nephrol"},{"key":"6629_CR7","doi-asserted-by":"publisher","first-page":"154732","DOI":"10.1016\/j.cyto.2019.05.019","volume":"121","author":"AF Lafalla Manzano","year":"2019","unstructured":"Lafalla Manzano AF, Gil Lorenzo AF, Bocanegra V et al (2019) Rab7b participation on the TLR4 (Toll-like receptor) endocytic pathway in Shiga toxin-associated Hemolytic Uremic Syndrome (HUS). Cytokine 121:154732. https:\/\/doi.org\/10.1016\/j.cyto.2019.05.019","journal-title":"Cytokine"},{"key":"6629_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00467-020-04829-4","volume":"36","author":"M Luna","year":"2021","unstructured":"Luna M, Kamariski M, Principi I et al (2021) Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage. Pediatr Nephrol 36:1499\u20131509. https:\/\/doi.org\/10.1007\/s00467-020-04829-4","journal-title":"Pediatr Nephrol"},{"key":"6629_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/microorganisms7010015","volume":"7","author":"S Buelli","year":"2019","unstructured":"Buelli S, Zoja C, Remuzzi G, Morigi M (2019) Complement activation contributes to the pathophysiology of Shiga toxin-associated hemolytic uremic syndrome. Microorganisms 7:15. https:\/\/doi.org\/10.3390\/microorganisms7010015","journal-title":"Microorganisms"},{"key":"6629_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1523-1755.2002.00503.x","volume":"62","author":"C Zoja","year":"2002","unstructured":"Zoja C, Angioletti S, Donadelli R et al (2002) Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-\u03baB dependent up-regulation of IL-8 and MCP-11. Kidney Int 62:846\u2013856. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00503.x","journal-title":"Kidney Int"},{"key":"6629_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","volume":"8","author":"M Noris","year":"2012","unstructured":"Noris M, Mescia F, Remuzzi G (2012) STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 8:622\u2013633. https:\/\/doi.org\/10.1038\/nrneph.2012.195","journal-title":"Nat Rev Nephrol"},{"key":"6629_CR12","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2215\/CJN.02730409","volume":"4","author":"JM Thurman","year":"2009","unstructured":"Thurman JM, Marians R, Emlen W et al (2009) Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1920\u20131924. https:\/\/doi.org\/10.2215\/CJN.02730409","journal-title":"Clin J Am Soc Nephrol"},{"key":"6629_CR13","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","volume":"117","author":"A St\u00e5hl","year":"2011","unstructured":"St\u00e5hl A, Sartz L, Karpman D (2011) Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli\u2013induced hemolytic uremic syndrome. Blood 117:5503\u20135513. https:\/\/doi.org\/10.1182\/blood-2010-09-309161","journal-title":"Blood"},{"key":"6629_CR14","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/ndt\/gfr748","volume":"27","author":"S Ge","year":"2012","unstructured":"Ge S, Hertel B, Emden SH et al (2012) Microparticle generation and leucocyte death in Shiga toxin-mediated HUS. Nephrol Dial Transplant 27:2768\u20132775. https:\/\/doi.org\/10.1093\/ndt\/gfr748","journal-title":"Nephrol Dial Transplant"},{"key":"6629_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molimm.2013.11.009","volume":"58","author":"K Poolpol","year":"2014","unstructured":"Poolpol K, Orth-H\u00f6ller D, Speth C et al (2014) Interaction of Shiga toxin 2 with complement regulators of the factor H protein family. Mol Immunol 58:77\u201384. https:\/\/doi.org\/10.1016\/j.molimm.2013.11.009","journal-title":"Mol Immunol"},{"key":"6629_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4049\/jimmunol.1100491","volume":"187","author":"M Morigi","year":"2011","unstructured":"Morigi M, Galbusera M, Gastoldi S et al (2011) Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187:172\u2013180. https:\/\/doi.org\/10.4049\/jimmunol.1100491","journal-title":"J Immunol"},{"key":"6629_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00467-016-3496-0","volume":"32","author":"D Westra","year":"2017","unstructured":"Westra D, Volokhina EB, van der Molen RG et al (2017) Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome. Pediatr Nephrol 32:297\u2013309. https:\/\/doi.org\/10.1007\/s00467-016-3496-0","journal-title":"Pediatr Nephrol"},{"key":"6629_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","volume":"41","author":"S Rodriguez de C\u00f3rdoba","year":"2004","unstructured":"Rodriguez de C\u00f3rdoba S, Esparza-Gordillo J, Goicoechea de Jorge E et al (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41:355\u2013367. https:\/\/doi.org\/10.1016\/j.molimm.2004.02.005","journal-title":"Mol Immunol"},{"key":"6629_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.it.2015.04.008","volume":"36","author":"M J\u00f3zsi","year":"2015","unstructured":"J\u00f3zsi M, Tortajada A, Uzonyi B et al (2015) Factor H-related proteins determine complement-activating surfaces. Trends Immunol 36:374\u2013384. https:\/\/doi.org\/10.1016\/j.it.2015.04.008","journal-title":"Trends Immunol"},{"key":"6629_CR20","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood.2020010069","volume":"137","author":"H Martin Merinero","year":"2021","unstructured":"Martin Merinero H, Sub\u00edas M, Pereda A et al (2021) Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases. Blood 137:3484\u20133494. https:\/\/doi.org\/10.1182\/blood.2020010069","journal-title":"Blood"},{"key":"6629_CR21","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2215\/CJN.08921209","volume":"5","author":"S Nathanson","year":"2010","unstructured":"Nathanson S, Kwon T, Elmaleh M et al (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5:1218\u20131228. https:\/\/doi.org\/10.2215\/CJN.08921209","journal-title":"Clin J Am Soc Nephrol"},{"key":"6629_CR22","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00467-018-4105-1","volume":"34","author":"M Khalid","year":"2019","unstructured":"Khalid M, Andreoli S (2019) Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol 34:2495\u20132507. https:\/\/doi.org\/10.1007\/s00467-018-4105-1","journal-title":"Pediatr Nephrol"},{"key":"6629_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00467-011-1973-z","volume":"27","author":"RC Rahman","year":"2012","unstructured":"Rahman RC, Cobe\u00f1as CJ, Drut R et al (2012) Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children. Pediatr Nephrol 27:229\u2013233. https:\/\/doi.org\/10.1007\/s00467-011-1973-z","journal-title":"Pediatr Nephrol"},{"key":"6629_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*. Pediatr Crit Care Med 6:2\u20138. https:\/\/doi.org\/10.1097\/01.PCC.0000149131.72248.E6","journal-title":"Pediatr Crit Care Med"},{"key":"6629_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0034-1375296","volume":"40","author":"S Rodr\u00edguez de C\u00f3rdoba","year":"2014","unstructured":"Rodr\u00edguez de C\u00f3rdoba S, Hidalgo M, Pinto S, Tortajada A (2014) Genetics of Atypical Hemolytic Uremic Syndrome (aHUS). Semin Thromb Hemost 40:422\u2013430. https:\/\/doi.org\/10.1055\/s-0034-1375296","journal-title":"Semin Thromb Hemost"},{"key":"6629_CR26","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","volume":"114","author":"C Abarrategui-Garrido","year":"2009","unstructured":"Abarrategui-Garrido C, Mart\u00ednez-Barricarte R, L\u00f3pez-Trascasa M et al (2009) Characterization of complement factor H\u2013related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood 114:4261\u20134271. https:\/\/doi.org\/10.1182\/blood-2009-05-223834","journal-title":"Blood"},{"key":"6629_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.imbio.2016.09.002","volume":"222","author":"M Sub\u00edas Hidalgo","year":"2017","unstructured":"Sub\u00edas Hidalgo M, Martin Merinero H, L\u00f3pez A et al (2017) Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment. Immunobiology 222:363\u2013371. https:\/\/doi.org\/10.1016\/j.imbio.2016.09.002","journal-title":"Immunobiology"},{"key":"6629_CR28","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.kint.2017.03.041","volume":"92","author":"A Tortajada","year":"2017","unstructured":"Tortajada A, Guti\u00e9rrez E, Goicoechea de Jorge E et al (2017) Elevated factor H\u2013related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy. Kidney Int 92:953\u2013963. https:\/\/doi.org\/10.1016\/j.kint.2017.03.041","journal-title":"Kidney Int"},{"key":"6629_CR29","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/ndt\/gfw078","volume":"31","author":"T Ahlenstiel-Grunow","year":"2016","unstructured":"Ahlenstiel-Grunow T, Hachmeister S, Bange FC et al (2016) Systemic complement activation and complement gene analysis in enterohaemorrhagic Escherichia coli -associated paediatric haemolytic uraemic syndrome. Nephrol Dial Transplant 31:1114\u20131121. https:\/\/doi.org\/10.1093\/ndt\/gfw078","journal-title":"Nephrol Dial Transplant"},{"key":"6629_CR30","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2215\/CJN.05830518","volume":"14","author":"V Fr\u00e9meaux-Bacchi","year":"2019","unstructured":"Fr\u00e9meaux-Bacchi V, Sellier-Leclerc A-L, Vieira-Martins P et al (2019) Complement gene variants and Shiga toxin-producing Escherichia coli\u2013associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 14:364\u2013377. https:\/\/doi.org\/10.2215\/CJN.05830518","journal-title":"Clin J Am Soc Nephrol"},{"key":"6629_CR31","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","volume":"12","author":"J Caprioli","year":"2003","unstructured":"Caprioli J, Castelletti F, Bucchioni S et al (2003) Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 12:3385\u20133395. https:\/\/doi.org\/10.1093\/hmg\/ddg363","journal-title":"Hum Mol Genet"},{"key":"6629_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/hmg\/ddi066","volume":"14","author":"J Esparza-Gordillo","year":"2005","unstructured":"Esparza-Gordillo J, de Jorge EG, Buil A et al (2005) Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 14:703\u2013712. https:\/\/doi.org\/10.1093\/hmg\/ddi066","journal-title":"Hum Mol Genet"},{"key":"6629_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03552.x","volume":"151","author":"SR De C\u00f3rdoba","year":"2007","unstructured":"De C\u00f3rdoba SR, De Jorge EG (2007) Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol 151:1\u201313. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03552.x","journal-title":"Clin Exp Immunol"},{"key":"6629_CR34","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1177\/2047487320931305","volume":"27","author":"JR Delanghe","year":"2020","unstructured":"Delanghe JR, De Buyzere ML, Speeckaert MM (2020) C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. Eur J Prev Cardiol 27:1331\u20131332. https:\/\/doi.org\/10.1177\/2047487320931305","journal-title":"Eur J Prev Cardiol"},{"key":"6629_CR35","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1074\/jbc.M114.605691","volume":"290","author":"E Rodriguez","year":"2015","unstructured":"Rodriguez E, Nan R, Li K et al (2015) A revised mechanism for the activation of complement C3 to C3b. J Biol Chem 290:2334\u20132350. https:\/\/doi.org\/10.1074\/jbc.M114.605691","journal-title":"J Biol Chem"},{"key":"6629_CR36","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1073\/pnas.0812584106","volume":"106","author":"T Montes","year":"2009","unstructured":"Montes T, Tortajada A, Morgan BP et al (2009) Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proc Natl Acad Sci U S A 106:4366\u20134371. https:\/\/doi.org\/10.1073\/pnas.0812584106","journal-title":"Proc Natl Acad Sci"},{"key":"6629_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4161\/viru.24642","volume":"4","author":"AI Etcheverr\u00eda","year":"2013","unstructured":"Etcheverr\u00eda AI, Padola NL (2013) Shiga toxin-producing Escherichia coli. Virulence 4:366\u2013372. https:\/\/doi.org\/10.4161\/viru.24642","journal-title":"Virulence"},{"key":"6629_CR38","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","volume":"182","author":"D Orth","year":"2009","unstructured":"Orth D, Khan AB, Naim A et al (2009) Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 182:6394\u20136400. https:\/\/doi.org\/10.4049\/jimmunol.0900151","journal-title":"J Immunol"},{"key":"6629_CR39","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00467-017-3876-0","volume":"33","author":"RA Exeni","year":"2018","unstructured":"Exeni RA, Fernandez-Brando RJ, Santiago AP et al (2018) Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 33:2057\u20132071. https:\/\/doi.org\/10.1007\/s00467-017-3876-0","journal-title":"Pediatr Nephrol"},{"key":"6629_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1681\/ASN.2017050518","volume":"29","author":"E Goicoechea de Jorge","year":"2018","unstructured":"Goicoechea de Jorge E, Tortajada A, Garc\u00eda SP et al (2018) Factor H competitor generated by gene conversion events associates with atypical hemolytic uremic syndrome. J Am Soc Nephrol 29:240\u2013249. https:\/\/doi.org\/10.1681\/ASN.2017050518","journal-title":"J Am Soc Nephrol"},{"key":"6629_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","volume":"56","author":"C Skerka","year":"2013","unstructured":"Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT (2013) Complement factor H related proteins (CFHRs). Mol Immunol 56:170\u2013180. https:\/\/doi.org\/10.1016\/j.molimm.2013.06.001","journal-title":"Mol Immunol"},{"key":"6629_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1006\/clim.2001.5043","volume":"100","author":"M N\u00e4rki\u00f6-M\u00e4kel\u00e4","year":"2001","unstructured":"N\u00e4rki\u00f6-M\u00e4kel\u00e4 M, Hellwage J, Tahkokallio O, Meri S (2001) Complement-regulator factor H and related proteins in otitis media with effusion. Clin Immunol 100:118\u2013126. https:\/\/doi.org\/10.1006\/clim.2001.5043","journal-title":"Clin Immunol"},{"key":"6629_CR43","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/humu.9408","volume":"27","author":"S Heinen","year":"2006","unstructured":"Heinen S, Sanchez-Corral P, Jackson MS et al (2006) De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum Mutat 27:292\u2013293. https:\/\/doi.org\/10.1002\/humu.9408","journal-title":"Hum Mutat"},{"key":"6629_CR44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/cei.12601","volume":"181","author":"JR Ferraris","year":"2015","unstructured":"Ferraris JR, Ferraris V, Acquier AB et al (2015) Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome. Clin Exp Immunol 181:118\u2013125. https:\/\/doi.org\/10.1111\/cei.12601","journal-title":"Clin Exp Immunol"},{"key":"6629_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00467-019-04334-3","volume":"35","author":"A Balestracci","year":"2020","unstructured":"Balestracci A, Meni Bataglia L, Toledo I et al (2020) C3 levels and acute outcomes in Shiga toxin\u2013related hemolytic uremic syndrome. Pediatr Nephrol 35:331\u2013339. https:\/\/doi.org\/10.1007\/s00467-019-04334-3","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06629-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06629-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06629-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T19:39:11Z","timestamp":1743277151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06629-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6629"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06629-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose. The results in this article have not been published previously in whole or part, including not being published in abstract form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}